ArticleHeliyon2025
Fluid volume status detection model for patients with heart failure based on machine learning methods.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Backgroud: Fluid volume abnormalities are a major cause of exacerbations in heart failure patients. However, there is few efficient, rapid, or cost-effective clinical approach for determining volume status, resulting in inadequate or unsatisfactory treatment. The aim was to develop an early fluid volume detection model for heart failure patients utilizing a machine learning stratification. Methods: The training set data collected by Tianjin Chest Hospital on heart failure patients from December 2016 to December 2021, included 2056 samples and 97 medical characteristics. The minimum Redundancy Maximum Relevance(mRMR) feature selection method was utilized to filter features that were strongly related to the patient's fluid volume status. Four machine learning classification models were used to predict patients' fluid volume status, and their effectiveness was measured using the receiver operating characteristic (ROC) area under the curve (AUC), calibration curve, accuracy, precision, recall, F1 score, specificity, and sensitivity. Data from 186 heart failure patients collected between January 2022 and July 2022 were employed as an external validation set to investigate the effects of model training. SHapley Additive exPlanations (SHAP) were used to interpret the ML models. Results: Thirty features were selected for model development, and the area under the ROC curve AUC (95 % CI) for the four machine learning models in the testing set was 0.75 (0.73-0.77), 0.77 (0.74-0.79), 0.70 (0.67-0.73), and 0.76 (0.73-0.78), and the AUC (95 % CI) in the external validation set was 0.74 (0.71-0.76), 0.70 (0.67-0.73), 0.64 (0.59-0.68), and 0.67 (0.63-0.71). Logistic regression models were globally interpreted using SHAP-based summary plots. Conclusions: Machine learning methods are effective in detecting fluid volume status in heart failure patients and can assist physicians with assisted diagnosis, thus helping clinicians to tailor precise management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.